TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
194
|
136 |
| Financial expenses |
2
|
0
|
0 |
| Earnings before taxes |
-1
|
128
|
81 |
| EBITDA |
-3
|
128
|
81 |
| Total assets |
201
|
226
|
131 |
| Current assets |
201
|
224
|
128 |
| Current liabilities |
22
|
46
|
29 |
| Equity capital |
176
|
177
|
102 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
87.6%
|
78.3%
|
77.9% |
| Turnover per employee |
0
|
194
|
136 |
| Profit as a percentage of turnover |
66.0%
|
59.6% | |
| Return on assets (ROA) |
0.5%
|
56.6%
|
61.8% |
| Current ratio |
913.6%
|
487.0%
|
441.4% |
| Return on equity (ROE) |
-0.6%
|
72.3%
|
79.4% |
| Change turnover |
-195
|
69
|
124 |
| Change turnover % |
-100%
|
56%
|
1011% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.